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The development of CRISPR/Cas9 technologies has dramatically
increased the accessibility and efficiency of genome editing in many
organisms. In general, in vivo germline expression of Cas9 results in
substantially higher activity than embryonic injection. However, no
transgenic lines expressing Cas9 have been developed for the major
mosquito disease vector Aedes aegypti. Here, we describe the gen-
eration of multiple stable, transgenic Ae. aegypti strains expressing
Cas9 in the germline, resulting in dramatic improvements in both the
consistency and efficiency of genome modifications using CRISPR.
Using these strains, we disrupted numerous genes important for
normal morphological development, and even generated triple mu-
tants from a single injection. We have also managed to increase the
rates of homology-directed repair by more than an order of magni-
tude. Given the exceptional mutagenic efficiency and specificity of
the Cas9 strains we engineered, they can be used for high-throughput
reverse genetic screens to help functionally annotate the Ae. aegypti
genome. Additionally, these strains represent a step toward the de-
velopment of novel population control technologies targeting Ae.
aegypti that rely on Cas9-based gene drives.
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The yellow fever mosquito, Aedes aegypti, is the principalvector of many arboviruses, such as dengue, chikungunya,
yellow fever, and zika. These pathogens are globally widespread
and pose significant epidemiological burdens on infected pop-
ulations, resulting in hundreds of millions infections and over
50,000 deaths per year (1–4). Due to the hazards they impose,
many methods for controlling Ae. aegypti populations have been
implemented, with the most common being chemical insecti-
cides. However, chemical control has proven incapable of stop-
ping the spread of Ae. aegypti, primarily due to the mosquito’s
ability to rapidly adapt to new climates, tendency to oviposit in
minimal water sources, desiccation-tolerant eggs, and quick de-
velopment of insecticide resistance (5, 6). Therefore, significant
efforts are currently underway to discern the underlying molec-
ular and genetic mechanisms important for arboviral vector
competence, with the overall aim of developing insecticide-free
ways to disrupt viral disease cycles (7). Importantly, uncovering
these mechanisms hinges on the ability to stably insert and dis-
rupt specific genes-of-interest through tailored genome engi-
neering in a target-specific manner. Fortunately, several tools
have been successfully employed in mosquitoes for targeted ge-
nome engineering that rely on either zinc finger nucleases (8–
10), transcription activator-like effector nucleases (TALENs)
(11, 12), or even homing endonuclease genes (13). However,
because they rely on context-sensitive modular protein–DNA-
binding interactions, each of these designer nucleases are time-
consuming and complicated to engineer and validate, making
them onerous for routine use in most laboratories.
To overcome the significant limitations posed by previous
genome-editing tools, the clustered regularly interspaced short
palindromic repeats/CRISPR-associated sequence 9 (CRISPR/
Cas9) system, originally discovered in bacteria and archaea (14–
20), has been adapted as a programmable (20, 21) precision
genome-editing tool in a diversity of organisms (22–29), in-
cluding mosquitoes (30–34). Briefly, the CRISPR/Cas9 system is
guided by a chimeric programmable synthetic short-guide RNA
(sgRNA) (20) that binds Cas9, directing it to a user-specified
genomic DNA target sequence, via Watson–Crick base pairing
between the sgRNA and the target DNA sequence, thereby
generating site-specific double-strand (ds) DNA breaks. This
system can be easily reprogrammed to modify virtually any de-
sired genomic sequence by recoding the specificity-determining
sequence of the sgRNA. Recoding constraints are minimal and
simply require that the target sequence is unique, compared with
the rest of the genome, and is located just upstream of a pro-
tospacer adjacent motif (PAM sequence), typically consisting of
the three nucleotide motif NGG (20, 21). Both the minimal
constraints and ease of use make CRISPR/Cas9 a powerful tool
for genome-engineering applications.
Importantly, CRISPR-mediated genome engineering of or-
ganisms has been achieved in a variety of different ways. For
example, direct injection of in vitro-purified sgRNAs combined
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with either purified Cas9 RNA, recombinant Cas9 protein, or
even with Cas9 expression plasmids, have all been successful for
a variety of organisms (29, 32, 35–40), including mosquitoes (30–
34). However, the rate of mutagenesis and lethality have varied
widely, both within and among these different studies, and such
discrepancies are likely due to either the methods used to in-
troduce the editing components, the variability in sgRNA func-
tionality against target sites, or even unavoidable variability from
manual injection of the components (41). To overcome these
significant limitations, previous studies in other organisms have
shown that stably expressing a transgenic provision of Cas9 in the
germline can decrease toxicity to injected embryos, increase the
rates of mutagenesis generated by both nonhomologous end
joining (NHEJ) and homology-directed repair (HDR), and can
also increase the rates of germline transmission of the disrupted
allele to offspring (27, 41–46).
Germline expression of Cas9 is also essential for developing
innovative technologies that rely on “gene drive,” which is a
novel strategy proposed for the control of vector-borne diseases
by rapidly spreading alleles in a population through super-
Mendelian inheritance (47, 48). In mosquitoes, gene drives
could potentially be used to rapidly disseminate a genetic pay-
load that reduces pathogen transmission throughout a pop-
ulation, thereby suppressing vector competence and human
disease transmission. Other possible applications include the
suppression of the population by spreading alleles that impair
fertility or viability (49, 50). A CRISPR homing-based gene-drive
element consists of only a few components, such as an sgRNA
and a germline-expressed Cas9 endonuclease that is positioned
opposite its target site in the genome. The drive encodes the
editing machinery (i.e., Cas9 and sgRNA), allowing it to cut the
opposite allele and copy itself into this disrupted allele via HDR,
thereby converting a heterozygote into a homozygote, enabling
rapid invasion of the drive into a population. In fact, Cas9 has
been used to develop highly promising homing-based gene drives
in a number of organisms, including yeast (51), Drosophila (52),
and Anopheles mosquitoes (52, 53); however, such a system has
yet to be developed in Ae. aegypti.
We therefore aimed to develop a CRISPR/Cas9 transgenic
system that would enable more robust and widespread Ae. aegypti
genome-engineering applications, including disrupting genes
important for vector competence, while also laying the founda-
tion for the future development of gene drives. To do so, we
utilized several previously described transcriptional regulatory
elements (54, 55), many of which are active in the germline (56),
to drive expression of Streptococcus pyogenes Cas9 in Ae. aegypti.
In total, we developed six independent Cas9 expressing strains,
and herein characterize and demonstrate their effectiveness for
gene disruption and gene insertion via HDR. We demonstrate
the efficiency of using these strains by disrupting six genes in Ae.
aegypti, giving rise to severe phenotypes, such as having an extra
eye (triple eyes), an extra maxillary palp (triple maxillary palps),
a nonfunctional curved proboscis, malformed wings, eye pig-
mentation deficiencies, and pronounced whole-animal cuticle
coloration defects. Furthermore, we also demonstrate the ease of
generating double- and triple-mutant strains simultaneously
from a single injection, a technique that will facilitate the ease of
gene-function study in this nonmodel organism. Overall, gene-
disruption efficiencies, survival rates, germline-transmission fre-
quencies, and HDR rates were all significantly improved using
the Cas9 strains we develop here. These strains should be highly
valuable for facilitating the development of innovative control
methods in this organism in the future.
Results
Construction of a Simple Transgenic CRISPR/Cas9 System for Ae. aegypti
Mutagenesis. To express Cas9 in the germline of Ae. aegypti, we
established transgenic mosquitoes harboring genomic sources of
Cas9. To promote robust expression of Cas9, we utilized pro-
moters from six genes including AAEL010097 (Exuperentia),
AAEL007097 (4-nitrophenylphosphatase), AAEL007584 (trunk),
AAEL005635 (Nup50), AAEL003877 (polyubiquitin), and
AAEL006511 (ubiquitin L40), due to their constitutive high levels of
expression during many developmental life stages (AAEL003877,
AAEL006511, AAEL005635), or high levels of expression in the
ovary triggered by uptake of a blood meal (AAEL010097,
AAEL007097, AAEL007584), as evidenced from previous pro-
moter characterization experiments or developmental transcrip-
tional profiling (54–56) (Fig. 1 A and B). We inserted these various
promoter fragments into a piggybac transposon upstream of the
coding sequence for spCas9. Downstream to the promoter-driven
Cas9 we included a self-cleaving T2A peptide and eGFP coding
sequence, together serving as a visual indicator of promoter activity.
We also included a baculovirus-derived Opie2 promoter (57) driv-
ing dsRed expression serving as a transgenesis marker (Fig. 1C).
The piggybac transgenes were injected into the germline of wild-
type embryos (Ae. aegypti genome sequence strain Liverpool) (58),
and transgenic mosquitoes harboring these transgenes were readily
identified by bright dsRed fluorescent expression in the abdomen
(SI Appendix, Fig. S1). We established stable transgenic strains
and dissected the germline tissues from each strain to assess
promoter activity, and found moderate levels of eGFP present
in the 0- to 24-h postblood meal ovary of the AAEL006511-
Cas9 and AAEL010097-Cas9 line, and very-weak yet detectable
levels of eGFP present in lines AAEL007097-Cas9, AAEL007584-
Cas9, and AAEL005635-Cas9. The AAEL010097-Cas9 and
AAEL006511-Cas9 lines also exhibited very-weak expression in
the 4-d-old testes. Finally, the AAEL003877-Cas9 line exhibited
no detectable eGFP signal, consistent with previous work in-
dicating this promoter does not express in the germline (55)
(Fig. 1D). Importantly, we were able to establish homozygous
stocks for each line, demonstrating that no significant toxicity is
associated with high transgenic expression of Cas9.
Germline Expression of Cas9 in Ae. aegypti Increases Targeting
Efficiency. To test the efficacy of our transgenic Ae. aegypti Cas9
strains, we first attempted to mutate the kynurenine hydroxylase
(kh) gene (AAEL008879), which was previously characterized as
having an easily detectable dominant mutant eye phenotype, as
the loss of kh gene function leads to severe eye pigmentation
defects (31). To do so, we designed a sgRNA (Kh-sgRNA) tar-
geting exon 4 of the kh gene, and to test its functionality we
coinjected this in vitro-transcribed Kh-sgRNA into 450 wild-type
embryos [referred to as generation 0 (G0)] along with purified
recombinant Cas9 protein. Following injection, complete white-
eye and partial mosaic white-eye mutants were readily observed
in adults (SI Appendix, Fig. S2). The G0s had a survival rate of
35 ± 7% and a mutagenesis efficiency of 17 ± 3%, and a mutant
heritability rate of 33 ± 7% in the G1 generation (Table 1).
Once we confirmed functionality of the Kh-sgRNA using pu-
rified recombinant Cas9 protein, we then injected this Kh-
sgRNA separately into 450 embryos (three injections of 150
embryos in biological triplicate) collected from each of our
transgenic Ae. aegypti Cas9 strains without including recombi-
nant Cas9 protein ;in the injection mix. Complete white-eye and
mosaic white-eye mutants were readily observed in injected G0
mosquitoes from five of six lines, including AAEL010097-Cas9,
AAEL007097-Cas9, AAEL007584-Cas9, AAEL005635-Cas9,
and AAEL006511-Cas9. Notably, directly injecting Kh-sgRNAs
into these transgenic Cas9 expression lines resulted in significantly
higher G0 survival rates (61 ± 7%, 53 ± 4%, 63 ± 4%, 64 ± 6%,
and 63 ± 4%, respectively), increased G0 mutagenesis efficiencies
(85 ± 5%, 27 ± 6%, 52 ± 7%, 47 ± 3%, and 66 ± 4%, re-
spectively), and increased overall heritable G1 mutation rates
(60 ± 9%, 59 ± 6%, 59 ± 5%, 60 ± 6%, and 66 ± 3%, respectively)
compared with when Kh-sgRNA was coinjected with recombinant
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Fig. 1. Rationally chosen, native promoters drive strong expression of Cas9. Log2 RPKM expression values for AAEL010097, AAEL007097, AAEL007584,
AAEL005635, AAEL003877, and AAEL006511 were plotted across development. Samples include, from left to right: testis; male carcasses (lacking testes);
carcasses of females before blood feeding (NBF), and at 12-, 24-, 36-, 48-, and 72-h postblood meal (PBM); ovaries from NBF females and at 12-, 24-, 36-, 48-,
and 72-h PBM; embryos from 0–2 h through 72–76 h; whole larvae from first, second, third, and fourth instar; male pupae; female pupae (A). Genome browser
snapshots of AAEL010097, AAEL007097, AAEL007584, AAEL005635, AAEL003877, and AAEL006511, including expression tracks for both 72-h PBM ovaries
and testes. The light gray box indicates coding sequence; blue box represents promoter element with length indicated in bp; y axis shows the expression level
based on raw read counts (B). Schematic representation of the piggybac-mediated Cas9 construct including the S. pyogenes Cas9-T2A-eGFP gene driven by
selected promoters (blue), dsRed expressed under the control of the Opie2 promoter, which serves as a transgenesis marker. NLS represent nuclear locali-
zation signal (C). Confocal images using white light or GFP-filtering of transgenic Cas9 line ovaries (D). (Magnification, 200×.)
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Cas9 protein into wild-type embryos (Table 1). As reported
previously, homozygous viable kh mutants have a dramatic eye
pigmentation defect that can be visualized in larvae, pupae, and
adults (31) (Fig. 2A). To confirm the phenotypic defects de-
scribed above were due to mutagenesis of the kh gene, genomic
DNA spanning the target site was amplified from homozygous
mutant G1s (Fig. 2A) and sequenced, confirming the presence of
insertion/deletions (indels) in the Kh-sgRNA genomic DNA
target site (SI Appendix, Fig. S3). In contrast, Kh-sgRNA in-
jected directly into the AAEL003877-Cas9 strain failed to show
any visible mutant phenotypes in the G0 generation, presumably
due to lack of germline expression by this promoter (55).
Given that CRISPR/Cas9 targeting efficiency varies signifi-
cantly between loci and even between target sites within the
same locus (26, 27, 30, 36), we wanted to further investigate the
efficacy of these transgenic Cas9 expressing strains. We therefore
designed two additional sgRNAs targeting uncharacterized
conserved genes that may be useful for developing future control
methodologies Ae. aegypti. One sgRNA (W1-sgRNA) was
designed to target exon 3 of the white gene (AAEL016999) (SI
Appendix, Fig. S4A), which is the Aedes 1:1 ortholog to Droso-
philia melanogaster white and functions as an ATP-binding
cassette transporter important for red and brown eye-color
pigmentation (59, 60). Another sgRNA was designed to target
exon 2 of the yellow gene (AAEL006830) (SI Appendix, Fig.
S5A), which is the Aedes 1:1 ortholog to D. melanogaster yellow, a
gene important for melanization of the cuticle (61, 62). To initially
test their functionality, we coinjected either in vitro-transcribed
W-sgRNA or Y-sgRNA, separately, into 450 wild-type embryos
(three injections of 150 embryos in biological triplicate), each along
with purified recombinant Cas9 protein. Following injection, com-
plete white-eye and partial mosaic white-eye, or complete yellow-
body and partial mosaic yellow-body mutants were readily observed
in G0s, indicating that the sgRNAs are functional (Table 1 and SI
Appendix, Fig. S2A). Once sgRNA functionality was confirmed us-
ing recombinant Cas9 protein, we then injected these sgRNAs
separately into 450 embryos (three injections of 150 embryos in
biological triplicate) collected from each of our transgenic Ae.
aegypti Cas9-expressing strains without including recombinant
Cas9 protein in the injection mix. Similar to the Kh-sgRNA results
described above, remarkably higher survival rates, mutagenesis ef-
ficiencies, and heritable mutation rates were also achieved for
both W-sgRNA and Y-sgRNA when injected into all transgenic
Cas9 lines, except AAEL003877-Cas9 (Table 1). As in other
Dipterans, homozygous G1 mutants for white have dramatic eye
pigmentation defects, similar to the kh mutants, which can be
visualized in larvae, pupa, and adults (Fig. 2A). Additionally,
homozygous G1 mutants for yellow have a striking yellow cuticle
pigmentation defect that can be visualized in, larvae, pupae,
adults, and even eggs (Fig. 2 A and B). To confirm the phe-
notypic defects from these sgRNAs were due to mutagenesis of
the white and yellow genes, genomic DNA from homozygous
mutant G1s (Fig. 2A) was amplified spanning the target sites
and sequenced confirming the presence of indels in both the
W-sgRNA and Y-sgRNA genomic DNA target sites (SI Appendix,
Figs. S4 and S5). Altogether, these results indicate that the Ae.
aegypti transgenic Cas9 expression system that we generated can
effectively express Cas9 protein, and direct injection of in vitro-
transcribed sgRNAs is sufficient to rapidly disrupt function of
target genes of interest and generate highly heritable mutations.
Of all of the transgenic lines, the AAEL010097-Cas9 line con-
sistently showed the highest survival rate and efficiency of mu-
tagenesis. Therefore, we performed all subsequent experiments
using this strain.
Precise Gene Disruption in Ae. aegypti. To further measure the
efficacy of the AAEL010097-Cas9 line, we decided to target
additional genes causing readily visible phenotypes in related
organisms that have yet to be studied in Ae. aegypti. Specifically,
we chose genes AAEL005793, AAEL009950, AAEL009170, and
AAEL003240, which are conserved 1:1 orthologs with the
D. melanogaster genes ebony, deformed, vestigial, and sine oculis,
respectively. Ebony encodes the enzyme N-β-alanyl dopamine
(NBAD) synthetase that converts dopamine to NBAD. Loss of
ebony function increases black cuticle pigment in D. melanogaster
(63). Deformed is a homeobox-containing (Hox) transcription
factor, loss-of-function of this gene results in dramatic defects in
derivatives of the maxillary segments, mandibular segments, and
anterior segments in D. melanogaster (64). Vestigial encodes a
nuclear protein that plays a central role in the development of
the wings and loss of vestigial results in the failure of proper wing
development in D. melanogaster (65, 66). The sine oculis locus
encodes a homeodomain-containing protein, which plays an es-
sential role in eye development and loss of sine oculis function
leads disruption of the eye disk formation in D. melanogaster
(67, 68).
To disrupt these genes, a single sgRNA was designed (E-sgRNA,
D-sgRNA, So-sgRNA, V-sgRNA) to target an exon in each of
these genes (SI Appendix, Figs. S6–S9), and then individually
injected into 200 AEL010097-Cas9 embryos. Injection of E-sgRNA
resulted in 82% of G0s showing pronounced dark coloration of
the adult cuticle (SI Appendix, Fig. S2). These mutations were
heritable and we established homozygous viable stocks by pair-
wise mating G1s (Fig. 2A and Table 2). D-sgRNA injection
resulted in the death of more than 72% of G0 mosquitoes before
the pupal stage, indicating that this gene is critical for proper
Table 1. Summary of the injection, survival, and mutagenesis rates mediated by Kh-sgRNA, W1-sgRNA, and Y-sgRNA in wild-type and
Cas9-expressing lines
Ae. aegypti line Injected component* No. injected G0s G0 adult survivors, % G0 mosaic, % G1 mutant adult
†, %
Liverpool (wild-type) Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 67 ± 4,63 ± 5,61 ± 4 0, 0, 0 0, 0, 0
Liverpool (wild-type) Cas9 protein 450, 450, 450 39 ± 4,41 ± 4,44 ± 7 0, 0, 0 0, 0, 0
Liverpool (wild-type) Kh-sgRNA,W1-sgRNA,
Y-sgRNA /Cas9 protein
450, 450, 450 35 ± 7,40 ± 6,30 ± 8 17 ± 3,21 ± 3,18 ± 6 33 ± 7,32 ± 5,30 ± 6
AAEL010097-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 61 ± 7,71 ± 6,65 ± 7 85 ± 5,87 ± 6,90 ± 5 60 ± 9,69 ± 4,62 ± 4
AAEL007097-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 53 ± 4,58 ± 4,62 ± 9 27 ± 6,33 ± 4,31 ± 5 59 ± 6,56 ± 6,62 ± 5
AAEL007584-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 63 ± 4,55 ± 7,61 ± 5 52 ± 7,63 ± 8,57 ± 5 59 ± 5,51 ± 7,57 ± 9
AAEL005635-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 64 ± 6,67 ± 3,55 ± 4 47 ± 3,62 ± 7,49 ± 4 60 ± 6,50 ± 6,54 ± 4
AAEL003877-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 51 ± 9,61 ± 8,61 ± 7 0, 0, 0 0, 0, 0
AAEL006511-Cas9 Kh-sgRNA,W1-sgRNA,Y-sgRNA 450, 450, 450 63 ± 4,57 ± 5,59 ± 6 66 ± 4,73 ± 6,70 ± 7 66 ± 3,65 ± 3,67 ± 4
Biological triplicate consisting of three independent injections (each injection replicate with 150 embryos total 450 embryos) were performed and the
results are shown as the mean ± SE throughout table.
*sgRNA 100 ng/μL; Cas9 protein 300 ng/μL.
†The overall heritable mutation rate was calculated as the number of mutant G1s divided by the number of all G1s observed.
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Fig. 2. Severe mutant phenotypes caused by CRISPR/Cas9 mediated disruption. Larva, pupae, and adult phenotypes of wild-type, kh, white, yellow, and
ebony mutant G1s, respectively, with clearly distinguishable eye (kh and white) and cuticle pigment (yellow and ebony) defects (A). Embryo phenotypes of
wild-type (Left) and yellow mutants (Right) (B). Pupae and adult scanning electron microscopy images of the head of the deformed G0 mutants with three
compound eyes (Ce), three maxillary palps (Mp), furrowed eyes, and deformed mouthparts (arrows) (C). Pupae and adult scanning electron microscopy
images of the head of the sine oculis G0 mutants. Arrows point to the ectopic eyes (D). Images of pupae and adult wings of vestigial G0 mutants. Arrows point
to pronounced wing, halteres, and forked wing defects (E). (Magnifications: whole-body images, 20×; Insets, 100×; SEM images, 150×.)
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development. However, 87% of the mosquitoes that reached
adulthood exhibited severe mutant phenotypes including an extra
eye (triple eyes), mal-shaped proboscis, and even an extra maxillary
palp (triple maxillary palps) (Fig. 2C and Table 2). Unsurprisingly,
all surviving G0 mutant females failed to blood feed, preventing us
from establishing homozygous mutant lines. In So-sgRNA injected
mosquitoes, 61% of the surviving G0s had clearly visible eye defects
do to cell death in the primordium region (Fig. 2D and Table 2).
As with the deformed mutants, we were unable to establish ho-
mozygous sine oculis mutant lines because these mutations were
homozygous-lethal. Finally, 70% of V-sgRNA-injected G0s died at
the pupal stage, with many of the dead pupae showing deformed
rudimentary wing appendages (Fig. 2E). Of the few individuals that
survived to adulthood, 75% had undeveloped wings or halteres
(Fig. 2E and Table 2), inhibiting their ability to fly or mate, making
it impossible to establish homozygous mutant lines for this gene.
To confirm that the phenotypes described above were caused by
disruption of the specific genes targeted by the sgRNAs (E-
sgRNA, D-sgRNA, So-sgRNA, V-sgRNA), genomic DNA from
the mutants (Fig. 2 C–E) was amplified spanning the target sites
and sequenced confirming a selection of indels in both the genomic
DNA target sites (SI Appendix, Figs. S6–S9).
Multiple sgRNAs Dramatically Improve Mutagenesis Rates. To de-
termine if simultaneous injection of two sgRNAs into the em-
bryos of the AAEL010097-Cas9 line could induce higher
mutagenesis efficiencies and germline transmission rates, we
designed another sgRNA (W2-sgRNA) also targeting exon 3 of
the white gene (SI Appendix, Fig. S10). Initially we tested func-
tionality of the W2-sgRNA by coinjecting this guide with
recombinant Cas9 protein into wild-type embryos. We found that
this W2-sgRNA is efficient at generating mutations as 41 ± 7%
of injected embryos survived to adult, 19 ± 6% of adult survi-
vors showed the mosaic and white-eye mutant phenotypes, and
27 ± 5% G1s showed the mutant white-eye phenotype (Table
3). Similar to results described above, directly injecting the
W2-sgRNA into the embryos of the AAEL010097-Cas9 line,
resulted in higher survival rates (62 ± 6%), greater mutagenesis
efficiencies (67 ± 9%), and higher germline transmission rates
(56 ± 9%) (Table 3). Importantly, when we coinjected W1-sgRNA
(described above) and W2-sgRNA together into embryos of the
AAEL010097-Cas9 line, white mutants were obtained in the G0s
at an extremely higher frequency of 94 ± 3%, with a remarkable
G1 transmission frequency of 96 ± 3% (Table 3). Furthermore,
genomic sequencing confirmed that some of the injections gen-
erated large deletions spanning the genomic distance (∼350 bp)
between the W1-sgRNA and W2-sgRNA target sites (SI Appendix,
Fig. S10). Together, these results indicate that by simultaneous in-
jection of multiple sgRNAs targeting the same gene, higher muta-
genesis rates and large deletions can be readily achieved.
Highly Efficient Multiplex Gene Disruption from a Single Injection.
Given the laborious and time-consuming crossing required to
generate Ae. aegypti lines with mutations at multiple genes, we
explored whether double- or triple-gene knockout strains could
quickly be generated in one step by coinjecting a multiplexed
combination of sgRNAs targeting different genes. To do so, we
made four mixes, including three combinations of two sgRNAs,
including: W1-sgRNA and Y-sgRNA (mix 1); W1-sgRNA and
E-sgRNA (mix 2); Y-sgRNA and E-sgRNA (mix 3); and one
combination of three sgRNAs, W1-sgRNA, Y-sgRNA and
E-sgRNA (mix 4). We injected these four mixes separately into
200 embryos from the AAEL010097-Cas9 line. We found that
90%, 87%, 93%, and 94% of the G0-injected survivors contained
at least one mutant phenotype for the injection sets one to four,
respectively (Table 4). Furthermore, 90%, 88%, and 92% of the
G0 injected survivors had double-mutants when injected with sets
one to three, respectively (Table 4 and SI Appendix, Fig. S11).
When we coinjected a combination of three sgRNA (mix 4), we
found that 67% of the surviving G0 adults contained mutations
in all three genes targeted (Table 4 and SI Appendix, Fig. S11).
Furthermore, these mutations were heritable as homozygous
viable mutant stocks following pairwise mating of G1 multi-
mutants (Fig. 3). Together, these results demonstrate that si-
multaneous and heritable multiple gene disruptions can be
efficiently achieved by using transgenic expression of Cas9 and
this simple technique should facilitate the rapid understanding
of gene function and help tease apart gene networks in this
nonmodel organism.
Table 2. Summary of the injection, survival, and mutagenesis rates mediated by E-sgRNA, D-sgRNA, So-sgRNA, and V-sgRNA in
AAEL010097-Cas9 line
Ae. aegypti line
Injected
component*
No. injected
G0s G0 larva survivors (%)
G0 adult
survivors (%)
G0 mutant
adult (%)
G1s mutant
adult† (%)
AAEL010097-Cas9 E-sgRNA 200 115 (58) 112 (56) 92 (82) 751 (67)
AAEL010097-Cas9 D-sgRNA 200 122 (61) 33 (28) 29 (87) Lethal
AAEL010097-Cas9 So-sgRNA 200 104 (52) 98 (52) 59 (61) Lethal
AAEL010097-Cas9 V-sgRNA 200 134 (67) 40 (30) 22 (75) Lethal
*sgRNA 100 ng/μL.
†The overall heritable mutation rate was calculated as the number of mutant G1s divided by the number of all G1s observed.
Table 3. Summary of the injection, survival, and mutagenesis rates mediated by W1-sgRNA and W2-sgRNA in wild-type and
AAEL010097-Cas9 line
Ae. aegypti line Injected component* No. injected G0s G0 adult survivors, % G0 mosaic, % G1s mutant adult
† %
Liverpool (wild-type) W2-sgRNA /Cas9 protein 450 41 ± 7 19 ± 6 27 ± 5
Liverpool (wild-type) W1-sgRNA/W2-sgRNA /Cas9 protein 450 37 ± 5 34 ± 5 37 ± 9
AAEL010097-Cas9 W2-sgRNA 450 62 ± 6 67 ± 9 56 ± 9
AAEL010097-Cas9 W1-sgRNA/W2-sgRNA 450 61 ± 8 94 ± 3 96 ± 3
Biological triplicate consisting of three independent injections (each injection replicate with 150 embryos total 450 embryos) were performed and the
results are shown as the mean ± SE throughout table.
*sgRNA 100 ng/μL; Cas9 protein 300 ng/μL.
†The overall heritable mutation rate was calculated as the number of mutant G1s divided by the number of all G1s observed.
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Increased Rates of HDRwith dsDNA Donors.Given the exceedingly high
rate of NHEJ-induced mutation when using theAAEL010097-
Cas9 line, we wanted to assess knock-in rates mediated by HDR via
dsDNA donors in this line. Our strategy was to employ two donor
Table 4. Single injection of multiple sgRNAs into the embryos of AAEL010097-Cas9 line results in highly efficient rates of multigene
disruption
Injected
sgRNAs
Injected
embryos
G0 adult
survivors (%)
G0
mosaic (%)
Single mutant G0s (%); G1s* (%) Double-mutant G0s (%); G1s
† (%)
Triple-mutant
G0s (%);
G1s
‡ (%)
W Y E W/Y W/E Y/E W/Y/E
W1-sgRNA/
Y-sgRNA
200 122 (61) 110 (90) 4 (4); 170 (15) 7 (6); 238 (21) N/A, N/A 99 (90); 488 (43) N/A; N/A N/A; N/A N/A; N/A
W1-sgRNA/
E-sgRNA
200 113 (56) 98 (87) 7 (7); 141 (17) N/A; N/A 5 (5); 224 (27) N/A; N/A 86 (88); 390 (47) N/A; N/A N/A; N/A
Y-sgRNA/
E-sgRNA
200 102 (51) 95 (93) N/A; N/A 3 (3); 343(25) 5 (5); 261 (15) N/A; N/A N/A; N/A 87 (92); 536 (39) N/A; N/A
W1-sgRNA/
Y-sgRNA/
E-sgRNA
200 86 (43) 81 (94) 3 (4); 85 (11) 3 (4); 54(7) 1 (1); 23 (3) 5 (6); 131 (17) 9 (11); 101 (13) 6 (7); 162 (21) 54 (67); 85 (11)
N/A, not applicable.
*Single-mutant phenotype, W: white eye; Y: yellow body; E: dark body.
†Double-mutant phenotypes, W/Y: white eye and yellow body, W/E: white eye and dark body; Y/E yellow body and dark body.
‡Triple-mutant phenotypes, W/Y/E: white eye, yellow body, and dark body.
yellow/white G1 yellow/ebony/white G1yellow/ebony G1 ebony/white G1
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Fig. 3. Single injections of multiplexed sgRNAa robustly generate double- and triple-mutant mosquitoes. Larva, pupae, and adult G1 phenotypes for double-
mutants, including: yellow body and white eyes (yellow/white), a mixture of yellow and dark body (yellow/ebony), dark body and white eyes (ebony/white),
and one triple-mutant, which is a phenotypic mixture of yellow and dark body and white eyes (yellow/ebony/white). The striking differences between wild-
type and mutant larva, pupae and adult are highlighted. (Magnifications: whole-body images, 20×; Insets, 100×.)
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plasmids, a white-donor plasmid based on the W1-sgRNA and a
kh-donor plasmid based on the Kh-sgRNA. Each of these two
donor plasmids was designed to contain a dominant fluorescent
marker consisting of 3xP3-dsRed, expressing in the larvae and
adult photoreceptors, flanked by ∼1-kb homology arms that were
derived from the genomic sequence immediately flanking the
target cleavage sites (Fig. 4 A and B). We directly compared two
approaches: (i) coinjection of dsDNA donor combined with in
vitro transcribed sgRNA and purified recombinant Cas9 protein
into wild-type embryos; and (ii) coinjection of circular dsDNA
donor combined with in vitro transcribed sgRNA injected into
AAEL010097-Cas9 line embryos. For the first approach, a total of
600 embryos were separately injected for both the white-donor and
kh-donor, with a HDR rate of 0.15% and 0.14% (Table 5), re-
spectively. For the second approach, a total of 600 embryos from
the Ae. aegypti AAEL010097-Cas9 line were separately injected
for both the white-donor and kh-donor, with a HDR rate of 2.36%
and 2.48% (Table 5), respectively. Overall, we see a dramatic, yet
consistent, 15- to 17-fold increase in rates of HDR when using the
AAEL010097-Cas9 line compared with the nontransgenic method
of supplying Cas9. Gene-specific insertion of our donor cassettes
into the intended target sites was confirmed by subsequent genomic
PCR and sequencing (Fig. 4 A–C and SI Appendix, Fig. S12).
Discussion
Previous studies have demonstrated effective CRISPR/Cas9 ge-
nome editing in the mosquito Ae. aegypti (30–34); however, these
studies utilized a nontransgenic source of Cas9, limiting both
survivorship and editing efficiencies. To overcome these previous
limitations, and to reduce the complexity of injecting multiple
components (i.e., Cas9 and sgRNA), herein we developed a sim-
plified transgenic Cas9 expression system in Ae. aegypti, similarly
to what is routinely used in other organisms such as D. mela-
nogaster (27, 41, 42). Importantly, to achieve highly specific and
consistent genome modifications, we demonstrate that embryos
from these Cas9 strains need only be injected with easy-to-make
5’-GTCCTTCAGGTCGCTCCGGGGG-3’
White locus 
AAEL016999
AE025 AE026 AE027 AE028
AE023 AE024
Kh locus 
AAEL008879
AE017 AE018
5’-GGGAATGAATGCCGGATTCGAGG-3’
AE019 AE020 AE021 AE022
A
B
AE027/AE028
WT WD
-349 bp
-533 bp -525 bp
-745 bp
AE029/AE030
WT WD
AE019/AE020
WT KHD
AE021/AE022
WT KHD
C D
Homology left Homology right
Homology left Homology right
-----------------------
-------
-----------------------
-------
3xp3 DsRed
3xp3 DsRed
Fig. 4. Highly efficient site-specific integration via CRISPR-mediated HDR. Schematic representations of the white locus and white-donor construct (A), and
the kh locus and kh-donor construct (B). Exons are shown as boxes, coding regions are depicted in black and the 5′ and 3′ UTRs in gray. Locations and se-
quences of the sgRNA targets are indicated with the PAM shown in yellow. Black arrows indicate approximate positions and directions of the oligonucleotide
primers used in the study. The donor plasmids (blue) express fluorescent eye marker (3xp3-DsRed) inserted between regions of homology from the white and
kh locus, respectively (A and B). Gene amplification analysis confirms site-specific integration of the white-donor construct into the white locus using
combinations of genomic and plasmid donor-specific primers (933Cms3/933Cms4 expected 349 bp, and 933Cms5/933Cms6 expected 533 bp) (C), and also
confirms the integration of the kh-donor construct into the kh locus using combinations of genomic and plasmid donor specific primers (924ms3/
924ms4 expected 525 bp, and 924ms5/924ms6 expected 745 bp) with no amplification in wild-type (D). WT represents wild-type, WD represents knockin with
white-donor, KHD represents knockin with kh-donor. (Magnification: 20×.)
Table 5. Transgenic source of Cas9 results in increased rates of HDR with dsDNA donors
Ae. aegypti strain Injected component* Injected embryos
Adult G0
survivors (%)
HDR event
No. group
founders/total
group (%)
No. HDR
G1/total G1 (%)
Liverpool (wild-type) W1-sgRNA/Cas9/white-donor 600 251(41.83) 1/20 (5) 9/5,371 (0.15)
Liverpool (wild-type) Kh-sgRNA/Cas9/kh-donor 600 273 (45.50) 1/20 (5) 7/4,773 (0.14)
AAEL010097-Cas9 W1-sgRNA/white-donor 600 308 (51.33) 4/20 (20) 118/4,993 (2.36)
AAEL010097-Cas9 Kh-sgRNA/kh-donor 600 298 (49.67) 5/20 (25) 149/6,017 (2.48)
*The concentration of sgRNA is 100 ng/μL; Cas9 protein 300 ng/μL. white-donor and kh-donor plasmids 100 ng/μL.
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sgRNAs. By using these Cas9 strains, we disrupted multiple genes
that were either homozygous viable (kh, white, yellow, and ebony),
or homozygous lethal (deformed, sine oculis, vestigial), resulting in
dramatic phenotypes affecting viability, vision, flight, and blood
feeding, and therefore may be useful for developing control
strategies and genetic sexing techniques in the future. For exam-
ple, in a yellow mutant background, the endogenous gene encod-
ing yellow could be linked to the male-determining locus (32),
using CRISPR-mediated HDR, to generate a robust genetic sex-
ing system by which male embryos/larvae/adults would be dark and
female embryos/larvae/adults would be yellow.
An appealing advantage of our Cas9 transgenic system is the
ability to efficiently disrupt multiple genes simultaneously. We have
demonstrated that we can efficiently generate large deletions, or
even double- (yellow-white; ebony-white; yellow-ebony), or triple-
(yellow-ebony-white) mutants. Importantly, these multimutants can
rapidly be generated in a single-step approach by injecting multiple
sgRNAs into the embryos of the transgenic Cas9 strains, signifi-
cantly reducing downstream efforts. This rapid multiplex gene
knockout approach will be instrumental for dissecting gene net-
works in this nonmodel organism. While the Cas9 strains were
generated in the Liverpool genetic background, these strains can be
introgressed into other genetic backgrounds if desired.
The germline Cas9 strains developed here may also bring us one
step closer to engineering an effective CRISPR/Cas9-homing–
based gene drive system (47, 48) in this organism. Homing-based
drive systems rely on HDR to convert heterozygous alleles into
homozygous alleles in the germline, and have recently been suc-
cessfully engineered in two Anopheline mosquito species (51, 69).
While these studies were fruitful at significantly biasing rates of
Mendelian inheritance rates of the drive containing alleles, they
were severely limited by the rapid evolution of resistance alleles
generated by NHEJ, and are therefore not predicted to spread
into diverse wild populations (70). It was hypothesized that these
resistance alleles formed due to high levels of maternal deposition
of Cas9 in the embryo, and by restricting Cas9 expression to the
germline may subsequently increase rates of HDR and reduce
rates of NHEJ. In addition to restricting expression to the germ-
line, multiplexing of sgRNAs in the drive, and designing the drive
to target a critical gene have also been proposed as innovative
strategies to increase rates of HDR and reduce resistance caused
by NHEJ (47, 48, 70); however, these hypotheses remain to be
demonstrated. Notwithstanding, it will be interesting to determine
if our Ae. aegypti Cas9 strains, each with varying expression in the
germline, will be effective in a gene drive system designed for
Ae. aegypti. This would be straightforward to test in a molecularly
confined safe split-gene drive design where the Cas9 and the drive
are positioned at different genomic loci. In this split-design, the
Cas9 strains we developed can be directly tested without further
modification by simply genetically crossing with a split gRNA-
drive component and measuring rates of inheritance (49, 71–73).
While the CRISPR/Cas9 transgenic system developed here is
quite effective, it would be useful to have the ability to supply the
sgRNAs transgenically. In D. melanogaster, polymerase-3 pro-
moters have been utilized to express sgRNAs, and through ge-
netic crosses with Cas9 strains mutation efficiency could be
increased up to 100% (42, 43).
Furthermore, it should be noted, that a slight disadvantage of
these Cas9 strains for some groups may result from the fact that
these strains were generated in the Liverpool genetic back-
ground, which restricts genome modifications to only this back-
ground. However, this can easily be overcome by simply using
genetics to introgress these promoter-Cas9 transgenes into other
genetic backgrounds, or by generating new transgenic strains in
the desired background using the plasmids generated here.
Overall, our results demonstrate that our simplified transgenic
Cas9 system has improved capacity to rapidly induce highly ef-
ficient and specific targeted genome modifications, including
gene disruptions, deletions, and insertions. Given their high ef-
ficiencies, these Cas9 strains can be used to quickly generate
genome modifications allowing for high-throughput gene tar-
geting, thereby accelerating comprehensive functional annota-
tion of the Ae. aegypti genome.
Materials and Methods
Insect Rearing. Mosquitoes used in all experiments were derived from of the
Ae. aegypti Liverpool strain, which was the source strain for the reference
genome sequence (58).
Generation of Ae. aegypti Cas9 Transgenic Lines. Transgenic Ae. aegypti
Cas9 mosquitoes were created by injecting 0- to 1-h-old preblastoderm-stage
embryos with a mixture of piggybac vector containing the Cas9 expressing
plasmid designed above (200 ng/μL) and a source of piggyBac transposase
[phsp-Pbac, (200 ng/μL)] (74–76).
Characterization of AAEL010097-Cas9 Insertion Site. To characterize the
Cas9 insertion site for AAEL010097-Cas9, we utilized a previously described
inverse PCR protocol (77).
CRISPR Mediated Microinjections. Embryonic collection and CRISPR microin-
jections were performed following previously established procedures (30, 78).
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